Published in J Clin Microbiol on March 10, 2010
Two years after pandemic influenza A/2009/H1N1: what have we learned? Clin Microbiol Rev (2012) 1.31
Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic. Clin Microbiol Rev (2012) 1.23
Rapid detection of the H275Y oseltamivir resistance mutation in influenza A/H1N1 2009 by single base pair RT-PCR and high-resolution melting. PLoS One (2011) 1.02
Identification of oseltamivir resistance among pandemic and seasonal influenza A (H1N1) viruses by an His275Tyr genotyping assay using the cycling probe method. J Clin Microbiol (2010) 1.00
Ultrasensitive detection of drug-resistant pandemic 2009 (H1N1) influenza A virus by rare-variant-sensitive high-resolution melting-curve analysis. J Clin Microbiol (2011) 0.89
Relationships between A(H1N1)pdm09 influenza infection and infections with other respiratory viruses. Influenza Other Respir Viruses (2014) 0.86
A synonymous change in the influenza A virus neuraminidase gene interferes with PCR-based subtyping and oseltamivir resistance mutation detection. J Clin Microbiol (2011) 0.82
High-resolution melting approach to efficient identification and quantification of H275Y mutant influenza H1N1/2009 virus in mixed-virus-population samples. J Clin Microbiol (2011) 0.82
Community-acquired oseltamivir-resistant pandemic (H1N1) 2009 in child, Israel. Emerg Infect Dis (2010) 0.79
Oseltamivir-resistant pandemic (H1N1) 2009 treated with nebulized zanamivir. Emerg Infect Dis (2010) 0.79
Epidemiological changes of respiratory syncytial virus (RSV) infections in Israel. PLoS One (2014) 0.78
Detection of oseltamivir sensitive/resistant strains of pandemic influenza A virus (H1N1) from patients admitted to hospitals in Thailand. J Virol Methods (2011) 0.78
Return of pandemic H1N1 influenza virus. BMC Infect Dis (2014) 0.77
Possible recurrent pandemic (H1N1) 2009 infection, Israel. Emerg Infect Dis (2010) 0.76
Increase human metapneumovirus mediated morbidity following pandemic influenza infection. PLoS One (2012) 0.76
Identification of genetic determinants of influenza A virus resistance to adamantanes and neuraminidase inhibitors using biological microarray. Dokl Biochem Biophys (2015) 0.75
Is the association between hip fractures and seasonality modified by influenza vaccination? An ecological study. Osteoporos Int (2017) 0.75
Avian flu: isolation of drug-resistant H5N1 virus. Nature (2005) 6.66
Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep (2009) 4.36
Resistance of influenza viruses to neuraminidase inhibitors--a review. Antiviral Res (2000) 3.68
Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009. MMWR Morb Mortal Wkly Rep (2009) 3.27
Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy. AIDS (2006) 2.71
Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors. Virus Res (2004) 2.25
Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay. Antiviral Res (2002) 2.22
Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing. Antimicrob Agents Chemother (2009) 2.09
Oseltamivir-resistant pandemic (H1N1) 2009 influenza virus, October 2009. Wkly Epidemiol Rec (2009) 1.74
Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase. J Clin Virol (2009) 1.58
Detection of influenza A(H1N1)v virus by real-time RT-PCR. Euro Surveill (2009) 1.50
Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses. Drugs (2009) 1.41
Development of a novel real-time reverse-transcriptase PCR method for the detection of H275Y positive influenza A H1N1 isolates. J Virol Methods (2009) 1.04
H5N1 Oseltamivir-resistance detection by real-time PCR using two high sensitivity labeled TaqMan probes. J Virol Methods (2006) 1.01
Influenza antiviral susceptibility monitoring activities in relation to national antiviral stockpiles in Europe during the winter 2006/2007 season. Euro Surveill (2007) 1.01
Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus. Biochem Biophys Res Commun (2009) 0.99
Characterization of large mumps outbreak among vaccinated Palestinian refugees. J Clin Microbiol (2009) 0.89
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management. J Infect Dis (2005) 3.52
Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration. PLoS Med (2005) 3.17
Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nat Immunol (2008) 3.14
Transmission of drug-resistant HIV-1 is stabilizing in Europe. J Infect Dis (2009) 2.60
Adaptation to different human populations by HIV-1 revealed by codon-based analyses. PLoS Comput Biol (2006) 2.48
Rapid detection of blaKPC carbapenemase genes by real-time PCR. J Clin Microbiol (2008) 2.46
Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol (2002) 1.77
Evaluation of a multiplex real-time reverse transcriptase PCR assay for detection and differentiation of influenza viruses A and B during the 2001-2002 influenza season in Israel. J Clin Microbiol (2005) 1.64
Men who have sex with men, risk behavior, and HIV infection: integrative analysis of clinical, epidemiological, and laboratory databases. Clin Infect Dis (2011) 1.64
Threshold survey evaluating transmitted HIV drug resistance among public antenatal clinic clients in Addis Ababa, Ethiopia. Antivir Ther (2008) 1.62
Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach. Retrovirology (2009) 1.58
Mutation D30N is not preferentially selected by human immunodeficiency virus type 1 subtype C in the development of resistance to nelfinavir. Antimicrob Agents Chemother (2004) 1.54
Transient elevation of triiodothyronine caused by triiodothyronine autoantibody associated with acute Epstein-Barr-virus infection. Thyroid (2003) 1.44
Detection of Zika virus RNA in whole blood of imported Zika virus disease cases up to 2 months after symptom onset, Israel, December 2015 to April 2016. Euro Surveill (2016) 1.32
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics. Retrovirology (2013) 1.30
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes. J Acquir Immune Defic Syndr (2006) 1.27
H5-type influenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor NKp44. J Virol (2007) 1.08
Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent. Antimicrob Agents Chemother (2006) 1.08
Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations. PLoS One (2006) 1.07
Killing of avian and Swine influenza virus by natural killer cells. J Virol (2010) 1.03
Digital cell quantification identifies global immune cell dynamics during influenza infection. Mol Syst Biol (2014) 1.02
Isolation of genetically unrelated bla(NDM-1)-positive Providencia rettgeri strains in Israel. J Clin Microbiol (2013) 1.01
Limited cross-border infections in patients newly diagnosed with HIV in Europe. Retrovirology (2013) 1.01
Rapid detection of blaKPC carbapenemase genes by internally controlled real-time PCR assay using bactec blood culture bottles. J Clin Microbiol (2011) 0.99
Zika Virus Disease in Traveler Returning from Vietnam to Israel. Emerg Infect Dis (2016) 0.99
Stiff-person syndrome following West Nile fever. Arch Neurol (2004) 0.98
Identification of the Brucella melitensis vaccine strain Rev.1 in animals and humans in Israel by PCR analysis of the PstI site polymorphism of its omp2 gene. J Clin Microbiol (2002) 0.97
Possible transmission of pandemic (HIN1) 2009 virus with oseltamivir resistance. Emerg Infect Dis (2010) 0.97
Presence of viremia in patients with primary herpetic gingivostomatitis. Clin Infect Dis (2004) 0.96
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. BMC Infect Dis (2014) 0.96
Barkedji virus, a novel mosquito-borne flavivirus identified in Culex perexiguus mosquitoes, Israel, 2011. J Gen Virol (2013) 0.95
Adenovirus infections in hospitalized patients in Israel: epidemiology and molecular characterization. J Clin Microbiol (2010) 0.95
High rate of human bocavirus and adenovirus coinfection in hospitalized Israeli children. J Clin Microbiol (2007) 0.95
Elucidating the mechanisms of influenza virus recognition by Ncr1. PLoS One (2012) 0.94
Evaluation of Simplexa Flu A/B & RSV for direct detection of influenza viruses (A and B) and respiratory syncytial virus in patient clinical samples. J Clin Microbiol (2013) 0.94
An outbreak of adenovirus type 7 in a residential facility for severely disabled children. Pediatr Infect Dis J (2011) 0.94
RegaDB: community-driven data management and analysis for infectious diseases. Bioinformatics (2013) 0.93
The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum (2009) 0.92
Evaluation of four different systems for extraction of RNA from stool suspensions using MS-2 coliphage as an exogenous control for RT-PCR inhibition. PLoS One (2012) 0.91
NKp46 O-glycan sequences that are involved in the interaction with hemagglutinin type 1 of influenza virus. J Virol (2010) 0.91
Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients. Retrovirology (2012) 0.91
Onset of a pandemic: characterizing the initial phase of the swine flu (H1N1) epidemic in Israel. BMC Infect Dis (2011) 0.90
RNAi interference of XPO1 and Sm genes and their effect on the spliced leader RNA in Trypanosoma brucei. Mol Biochem Parasitol (2006) 0.89
Increased extent of and risk factors for pandemic (H1N1) 2009 and seasonal influenza among children, Israel. Emerg Infect Dis (2011) 0.89
Characterization of human metapneumovirus infections in Israel. J Clin Microbiol (2006) 0.89
The dynamics of infection and the persistence of immunity to A(H1N1)pdm09 virus in Israel. Influenza Other Respir Viruses (2012) 0.89
Development of oseltamivir resistance during oseltamivir therapy in a child with severe 2009 H1N1 influenza. Pediatr Infect Dis J (2010) 0.89
Characterization of large mumps outbreak among vaccinated Palestinian refugees. J Clin Microbiol (2009) 0.89
Diminished selection for thymidine-analog mutations associated with the presence of M184V in Ethiopian children infected with HIV subtype C receiving lamivudine-containing therapy. Pediatr Infect Dis J (2006) 0.88
Phylogenetic analysis of human parvovirus b19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b. J Clin Microbiol (2009) 0.87
Efficacy and safety of vaccination against pandemic 2009 influenza A (H1N1) virus among patients with rheumatic diseases. Arthritis Care Res (Hoboken) (2011) 0.87
T7 phage display of Ep15 peptide for the detection of WNV IgG. J Virol Methods (2007) 0.86
Comparative performance of the Amplicor HIV-1 Monitor Assay versus NucliSens EasyQ in HIV subtype C-infected patients. J Med Virol (2006) 0.86
Relationships between A(H1N1)pdm09 influenza infection and infections with other respiratory viruses. Influenza Other Respir Viruses (2014) 0.86
Oral poliovaccine: will it help eradicate polio or cause the next epidemic? Isr Med Assoc J (2006) 0.86